American Century Companies Inc. Buys 32,240 Shares of Teladoc Health, Inc. (NYSE:TDOC)

American Century Companies Inc. boosted its position in Teladoc Health, Inc. (NYSE:TDOC – Free Report) by 31.0% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 136,351 shares of the health services provider’s stock after purchasing an additional 32,240 shares during [...]

featured-image

American Century Companies Inc. boosted its position in Teladoc Health, Inc. ( NYSE:TDOC – Free Report ) by 31.

0% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 136,351 shares of the health services provider’s stock after purchasing an additional 32,240 shares during the period. American Century Companies Inc.



owned approximately 0.08% of Teladoc Health worth $1,334,000 as of its most recent filing with the Securities and Exchange Commission (SEC). A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock.

Vanguard Group Inc. raised its stake in Teladoc Health by 11.8% in the fourth quarter.

Vanguard Group Inc. now owns 17,515,127 shares of the health services provider’s stock valued at $377,451,000 after buying an additional 1,855,480 shares during the last quarter. Norges Bank acquired a new stake in shares of Teladoc Health during the fourth quarter worth $9,714,000.

Pale Fire Capital SE purchased a new position in Teladoc Health in the 4th quarter worth $8,960,000. Mizuho Markets Americas LLC acquired a new position in shares of Teladoc Health in the second quarter valued at about $3,937,000. Finally, Natixis boosted its position in Teladoc Health by 106.

6% in the first quarter. Natixis now owns 19,898 shares of the health services provider’s stock valued at $300,000 after buying an additional 319,898 shares during the last quarter. Institutional investors own 76.

82% of the company’s stock. Insider Activity at Teladoc Health In related news, CMO Stephany Verstraete sold 15,000 shares of Teladoc Health stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $7.

60, for a total value of $114,000.00. Following the completion of the sale, the chief marketing officer now owns 45,158 shares of the company’s stock, valued at approximately $343,200.

80. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website . In other Teladoc Health news, CEO Laizer Kornwasser sold 10,879 shares of the company’s stock in a transaction that occurred on Friday, August 2nd.

The stock was sold at an average price of $8.14, for a total value of $88,555.06.

Following the completion of the transaction, the chief executive officer now owns 99,929 shares of the company’s stock, valued at approximately $813,422.06. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink .

Also, CMO Stephany Verstraete sold 15,000 shares of the company’s stock in a transaction that occurred on Wednesday, August 7th. The shares were sold at an average price of $7.60, for a total value of $114,000.

00. Following the completion of the transaction, the chief marketing officer now directly owns 45,158 shares of the company’s stock, valued at approximately $343,200.80.

The disclosure for this sale can be found here . In the last 90 days, insiders sold 57,819 shares of company stock valued at $442,204. Insiders own 0.

95% of the company’s stock. Analysts Set New Price Targets Get Our Latest Stock Analysis on Teladoc Health Teladoc Health Trading Up 0.6 % Teladoc Health stock opened at $8.

46 on Monday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.

62 and a current ratio of 1.66. The firm has a market cap of $1.

43 billion, a price-to-earnings ratio of -6.00 and a beta of 0.90.

Teladoc Health, Inc. has a 1 year low of $6.76 and a 1 year high of $22.

54. The firm’s 50 day moving average price is $7.93 and its two-hundred day moving average price is $10.

62. Teladoc Health ( NYSE:TDOC – Get Free Report ) last posted its quarterly earnings data on Wednesday, July 31st. The health services provider reported ($0.

28) earnings per share for the quarter, topping the consensus estimate of ($0.36) by $0.08.

Teladoc Health had a negative net margin of 38.54% and a negative return on equity of 10.25%.

The firm had revenue of $642.44 million for the quarter, compared to analysts’ expectations of $649.34 million.

On average, research analysts predict that Teladoc Health, Inc. will post -1.18 EPS for the current fiscal year.

Teladoc Health Profile ( Free Report ) Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

Featured Articles Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health, Inc. ( NYSE:TDOC – Free Report ).

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter ..